Skip to main content
. 2017 Nov 17;131(3):301–310. doi: 10.1182/blood-2017-07-795047

Table 3.

Selected grade 3/4 adverse events

Patients with selected grade 3/4 adverse events Rd continuous (n = 532) Rd18 (n = 540) MPT (n = 541)
Hematologic, %
 Neutropenia 30 26 45
 Anemia 19 16 19
 Thrombocytopenia 9 8 11
 Febrile neutropenia 1 3 3
Nonhematologic, %
 Infections 32 22 17
  Pneumonia 9 8 6
 Cataract 7 3 1
 Deep vein thrombosis 5 4 3
 Diarrhea 5 3 1
 Pulmonary embolism 4 3 4
 Constipation 2 2 5
 Peripheral sensory neuropathy 1 <1 9